NCT02786238

Brief Summary

This study will be the first clinical trial to examine the impact of two different weight loss interventions on novel mechanisms that promote obesity and impede its successful treatment, including cognitive function and self-regulatory factors. The results will provide important data about how impaired cognitive function and/or self-regulation promote obesity and how different weight loss treatments may differentially impact these factors; this information will be used to identify promising cognitive and self-regulatory treatment targets for preventing further obesity development and for maintaining weight loss.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable obesity

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2016

Completed
19 days until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 30, 2016

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

2.4 years

First QC Date

April 12, 2016

Last Update Submit

January 26, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • % Weight Loss Post-Treatment

    The percentage of weight loss at treatment completion (6 months after baseline).

    6 months after baseline

  • % Weight Loss at Follow-up

    The percentage of weight loss at one year after baseline (6 months post-treatment).

    One year after baseline

Secondary Outcomes (8)

  • Change in Insulin Levels

    Baseline to 6-months and Baseline to one-year

  • Change in Fasting Glucose

    Baseline to 6-months and Baseline to one-year

  • Change in Hemoglobin A1C

    Baseline to 6-months and Baseline to one-year

  • Change in C-Reactive Protein

    Baseline to one-year

  • Change in Tumor Necrosis Factor-Alpha

    Baseline to one-year

  • +3 more secondary outcomes

Study Arms (2)

Standard Behavioral Treatment (SBT)

ACTIVE COMPARATOR

For the Standard Behavioral Treatment (SBT) condition, participants will participate in the standard behavioral weight loss programming, which utilizes strategies from existing obesity treatments (e.g., the Diabetes Prevention Program). These features include the following: 1) nutritional education, 2) diet and physical activity, 3) expectations for daily self-monitoring of calorie intake and activity, 4) stimulus control, behavior shaping, behavior analysis, and relapse prevention strategies, and 5) social support.

Behavioral: Standard Behavioral Treatment (SBT)

Acceptance-Based Treatment (ABT)

EXPERIMENTAL

The Acceptance-Based Treatment (ABT) group will receive most features listed in the SBT arm as well as unique ABT training designed to help individuals increase awareness of their cognitive and affective experiences, and the following exercises: 1) identifying weight-related goals from personal life values (e.g., health) and connecting these values to day-to-day eating, 2) increasing awareness of moment-by-moment behavior choices, 3) tolerating aversive internal states that include eating-related states as well as affective states such as stress, sadness, and anxiety (i.e., "urge-surfing"). These strategies that have been empirically tested and found to be effective in the NIH-funded Mind Your Health RCT (R21DK080430).

Behavioral: Acceptance-Based Treatment (ABT)

Interventions

See description of treatment arm.

Standard Behavioral Treatment (SBT)

See description of treatment arm. \*\*Cherokee Nation members receive only the ABT intervention as they are in an open, feasibility trial and are not randomized.\*\*

Acceptance-Based Treatment (ABT)

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>21 years old
  • \<65 years old
  • BMI \> 27
  • BMI \< 52
  • Attended Information/Recruitment session
  • \*\*For Cherokee Nation arm of the study only, participants must endorse Native American/American Indian racial identity (POWER-UP).

You may not qualify if:

  • Age out of stated range
  • BMI out of stated range
  • Physician says physical activity is contraindicated (won't sign off) or participant meets the criteria on the Physical Activity Readiness Questionnaire (PARQ) for need a physician signature and doesn't obtain one.
  • History of bariatric surgery or planning to get surgery over next 12 months
  • Pregnant, planning to become pregnant over next 12 months
  • Currently breastfeeding
  • Failure of Independence (a family member/friend enrolling in study)
  • History or current serious eating disorder pathology
  • Current severe depression or suicidal ideation
  • Current severe anxiety
  • History or current substance use disorder
  • History of hypomanic or manic episode
  • History of psychotic episode
  • History of neurological disorder or head injury (e.g., stroke, epilepsy, loss of consciousness \>10 min)
  • Recent significant weight loss
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hawkins MAW, Colaizzi J, Gunstad J, Hughes JW, Mullins LL, Betts N, Smith CE, Keirns NG, Vohs KD, Moore SM, Forman EM, Lovallo WR. Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments. Contemp Clin Trials. 2018 Mar;66:20-27. doi: 10.1016/j.cct.2017.12.010. Epub 2017 Dec 22.

    PMID: 29274893BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2016

First Posted

May 30, 2016

Study Start

May 1, 2016

Primary Completion

October 1, 2018

Study Completion

August 1, 2020

Last Updated

January 27, 2021

Record last verified: 2021-01